Shawn Flanagan
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 08, 2025
Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study.Roxana E Rojas, Ozlem Equils, Jorge Villacian
|Mar 18, 2025
Drug-Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice.Simon Döhrmann, James Levin, Jason N Cole
|Jun 06, 2024
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects.Shawn Flanagan, Voon Ong, Thomas Marbury
|Nov 28, 2023
Population pharmacokinetic modeling and target attainment analyses of rezafungin for the treatment of candidemia and invasive candidiasis.Stefan Roepcke, Julie Passarell, Helen Walker
Pageof 1
Frequent Collaborators
1 joint publications
Julie Passarell
1 joint publications
Helen Walker
1 joint publications
Voon Ong
1 joint publications
Thomas Marbury
1 joint publications
Ronak G Gandhi
1 joint publications
Jeffrey B Locke
1 joint publications
Leslie W Tari
1 joint publications
Wilbert van Duijnhoven
1 joint publications
Tristan Baguet
